ArticleTherapeutic innovation & regulatory science2024

Recent Status of Phase I Clinical Trials for Brain Tumors: A Regulatory Science Study of Exploratory Efficacy Endpoints.

Shinya Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.